Frontlight ResearchEarly access
Trial site
Chiang Mai
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria3 trials
- Chronic myeloid leukaemia2 trials
- Familial hypercholesterolaemia2 trials
- Immune thrombocytopenia (ITP)2 trials
- Lupus (SLE)2 trials
- Ankylosing spondylitis1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Metastatic breast cancer1 trial
- Migraine1 trial
- Myelodysplastic syndromes1 trial
- Psoriasis1 trial
- and 2 more
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026